Previous 10 | Next 10 |
Becton, Dickinson and Company (NYSE:BDX) on Wednesday said it was voluntarily recalling some of its intraosseous products due to some issues. The products being recalled are certain lots of the BD Intraosseous Needle Set Kits, BD Intraosseous Manual Driver Kits and BD Intraosseous Powered Dri...
BD Announces Voluntary Recall on Intraosseous Products PR Newswire FRANKLIN LAKES, N.J. , June 22, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company), a leading global medical technology company, announced a voluntary recall on the BD™ In...
Eastern Health and BD Implement Innovative Solution with Goal of Reducing Consumption of Antibiotics and Other Medications Canada NewsWire A first in Canada , implementing the BD HealthSight™ combines timely surveillance to support the early detection of emerg...
Becton, Dickinson (NYSE:BDX -1.8%) said on Monday it was collaborating with Mayo Clinic Platform to access patient data to perform post-market surveillance on its products. (BDX) will get access to de-identified data sets available from 10 million patients, including both structured and ...
BD Collaborates with Mayo Clinic Platform, Leveraging Real-World Clinical Data to Improve Post-Market Device Surveillance, Drive Innovation for Patient Care PR Newswire BD is among the first companies to enter innovative partnership with Mayo Clinic Platform for acce...
Becton, Dickson and Company ( NYSE: BDX ), a top medical tech corporation also known as BD, and leading private equity company, Frazier Healthcare Partners, announced they had entered into a definitive merger agreement whereby BD is to acquire Parata for a consideration price of...
Becton, Dickinson and Company (NYSE:BDX) and CerTest Biotec, a European diagnostic device maker, announced a collaboration on Wednesday to develop a molecular diagnostic test for the Monkeypox virus. The assay will be available for the users of Becton’s (BDX) BD MAX System, an automate...
CerTest Biotec and BD Announce Collaboration on Molecular Diagnostic Test for Monkeypox PR Newswire CerTest Biotec Uses the BD MAX™ Molecular Diagnostic System Open System Reagent Suite to Develop RT-PCR Detection Kit ZARAGOZA, Spain and FR...
BD Names Simon Campion as Medical Segment President PR Newswire FRANKLIN LAKES, N.J. , June 7, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has appointed Simon Campi...
Becton, Dickinson and Company (NYSE:BDX) and Frazier Healthcare Partners have signed a definitive agreement to acquire Parata Systems, innovative provider of pharmacy automation solutions. The purchase consideration is set to $1.525B in all-cash transaction. Parata provides pharmacy technolog...
News, Short Squeeze, Breakout and More Instantly...
Becton Dickinson and Company Company Name:
BDX Stock Symbol:
NYSE Market:
Becton Dickinson and Company Website:
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases PR Newswire Collaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J. , July 25, 20...
2024-07-11 12:00:00 ET July 11, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at recent news and developments in the blood infections treatment market, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:C...
BD Statement on Supplier Issue Impacting BD BACTEC™ Blood Culture Vials PR Newswire Company Committed to Support Global Health and Customers BD Taking all Available Measures to Mitigate Supplier Issue FRANKLIN LAKES, N.J. , July 10 , 2024...